Clonal monocytosis of undetermined significance

Biomarker

2 papers mention it3 findings

See all 2 papers on clonal monocytosis of undetermined significance

“CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease.”
The prevalence and clinical significance of clonal monocytosisBlood2026doi:10.1182/blood.2025031883

Associations

3

Kidney disease

upin humans1

1 study
  1. Clonal monocytosis of undetermined significance is linked with a higher risk of kidney disease in humans.

    “CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease.”

    Humansbloodn = 431,531

    Two blood conditions linked to higher blood cancer risk

    Blood

More on Kidney disease

Cardiovascular disease

upin humans1

1 study
  1. Clonal monocytosis of undetermined significance is linked with a higher risk of cardiovascular disease in humans.

    “CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease.”

    Humansbloodn = 431,531

    Two blood conditions linked to higher blood cancer risk

    Blood

More on Cardiovascular disease

Myeloid neoplasia

upin humans1

1 study
  1. Clonal monocytosis of undetermined significance is linked with a higher risk of myeloid neoplasia in humans.

    “CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease.”

    Humansbloodn = 431,531

    Two blood conditions linked to higher blood cancer risk

    Blood

More on Myeloid neoplasia

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 02 papers in 12 months
Blood

Two blood conditions linked to higher blood cancer risk

Ten-year blood cancer incidence reached 18.5% with mutations, low blood counts and elevated monocytes—immune cells—versus 5.3% with mutations and low counts without…Ten-year blood cancer incidence reached 18.5% with mutations, low blood counts and elevated monocytes—immune cells—versus 5.3% with mutations and low counts without elevated monocytes.

Cohort · 431,531 peopleBiomarkers